Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-46550  Staphylococcus aureus subsp. aureus, JE2, Transposon Mutant NE7 (SAUSA300_1425)
(Mutant Bacteria)
Price: All BEI Resources products are provided
at no cost to registered researchers.
Organism: Staphylococcus aureus subsp. aureus
Designations: JE2, Transposon Mutant NE7 (SAUSA300_1425)
Biosafety Level: 2
Availability Status: In Stock
Store at: -60°C or colder
Contributor: K Bayles, P Fey, NARSA
Comments:
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

Staphylococcus aureus (S. aureus) subsp. aureus, transposon mutant NE7 was derived from S. aureus subsp. aureus, strain JE2. Mutagenesis occurred through the use of the mariner-based transposon bursa aurealis resulting in an erythromycin-resistant deletion strain of JE2. S. aureus subsp. aureus, transposon mutant NE7 was created by disruption of SAUSA300_1425, which encodes for a hypothetical protein.

S. aureus subsp. aureus, strain JE2 is a plasmid-cured derivative of strain LAC that was isolated in 2002 from a skin and soft tissue infection of an inmate in the Los Angeles County Jail in California, USA. Strain JE2 is a methicillin-resistant S. aureus (MRSA) strain and is a USA300 isolate. USA300 isolates have the same MLST profile (ST 8), SCCmec (subtype IV), agr group (I) and spa motif (MBQBLO) and typically carry the Panton-Valentine leukocidin (PVL) toxin genes and the arginine catabolic mobile element (ACME). USA300 is the most common cause of community-associated MRSA infection and an increasing cause of hospital-acquired infections.

Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth containing 5 µg/mL erythromycin supplemented with 10% glycerol.

Note: If homogeneity is required for your intended use, please purify prior to initiating work. It is recommended that the presence and location of the transposon is confirmed.

The Nebraska Transposon Mutant Library (NTML) was constructed in the laboratories of Dr. Ken Bayles and Dr. Paul Fey at the University of Nebraska Medical Center. Additional information is available at the NTML website.
Citations: Acknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus subsp. aureus, Strain JE2, Transposon Mutant NE7 (SAUSA300_1425), NR-46550."
PERMITS
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top


Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.


Back to My Search